Alexander Hastings

Alex Hastings advises clients across a broad range of government contracting issues, including advising clients in transactional matters involving government contractors and assisting defense contractors and pharmaceutical companies in securing and performing government contracts.

Mr. Hastings also advises clients concerning best practices in e-discovery. He assists in investigations and litigations that involve complex e-discovery issues and has represented clients in matters involving the U.S. Department of Justice, Securities and Exchange Commission and the United States International Trade Commission.

Firm/Organization: Covington & Burling LLP

Blogs: Global Policy Watch, Inside Energy & Environment, Inside Government Contracts

Latest Articles

Global Policy Watch

Trump Administration Renews Focus on Anti-Human Trafficking Efforts

By Jennifer Plitsch, Frederic Levy & Alexander Hastings

January 14, 2020

The Trump Administration has declared this month National Slavery and Human Trafficking Prevention Month, calling on industry associations, law enforcement, private businesses, and others to work toward ending modern slavery and human trafficking. This proclamation follows the Administration’s efforts to combat human trafficking, which we have previously discussed here, and comes on the heels of an OMB memorandum released last fall aimed at “enhanc[ing] the effectiveness of anti-trafficking requirements in Federal acquisition while helping…

Inside Government Contracts

Trump Administration Renews Focus on Anti-Human Trafficking Efforts

By Jennifer Plitsch, Frederic Levy & Alexander Hastings

January 14, 2020

Global Policy Watch

Momentum In Drug Pricing Reform: House Passes New Legislation on the Heels of Presidential Candidates’ Drug Pricing Proposals

By Jennifer Plitsch, Alexander Hastings & Maria Adebayo*

December 20, 2019

Late last week, House Democrats passed Speaker Nancy Pelosi’s Elijah E. Cummings Lower Drug Costs Now Act. This bill would, among other things, permit the Department of Health and Human Services (“HHS”) to negotiate lower prices for 250 of the costliest drugs on behalf of Medicare beneficiaries and other consumers. Although this particular legislation appears to have little chance of passing the Senate and appears to lack support from President Trump, it comes on the…

Inside Government Contracts

Momentum In Drug Pricing Reform: House Passes New Legislation on the Heels of Presidential Candidates’ Drug Pricing Proposals

By Jennifer Plitsch, Alexander Hastings & Maria Adebayo*

December 19, 2019

Global Policy Watch

How Much Is Enough? Federal Circuit Appeal May Decide Level of U.S. Manufacturing Required Under the TAA

By Jennifer Plitsch, Alexander Hastings & Sarah Shepson

October 22, 2019

A long-standing dispute over the approach to country of origin determinations under the Trade Agreements Act (“TAA”) may soon be resolved, as the Federal Circuit recently heard oral argument in one of two cases presently examining key aspects of this statute. Among other questions presented, the court may decide the standard for determining whether a product may be considered a U.S.-made end product — a question that could have far reaching implications for product manufacturers…

Inside Government Contracts

How Much Is Enough? Federal Circuit Appeal May Decide Level of U.S. Manufacturing Required Under the TAA

By Jennifer Plitsch, Alexander Hastings & Sarah Shepson

October 22, 2019

Inside Government Contracts

Rights in Government-Funded IP: Changes May be on the Horizon

By Jennifer Plitsch, Alexander Hastings, Bryan Byrd & Carl Wiersum

May 3, 2019

Many entities engaged in federally funded R&D have closely monitored the efforts of the National Institute of Standards and Technology (“NIST”) over the last year as it has studied strategies for maximizing U.S. innovation through government-funded research. Last week, NIST published its findings in NIST Special Publication 1234, Return on Investment Initiative for Unleashing American Innovation Green Paper (“Green Paper”). Benefiting from information received from an initial Request for Information, public meetings, a…

Inside Government Contracts

More Novation Complexity In Gov’t Contracts M&A?

By Scott A. Freling, Alexander Hastings & Andrew Guy

December 5, 2018

(This article was originally published in Law360 and has been modified for this blog.) Government contractors undergoing an asset transaction know all too well the peculiarity and uncertainty associated with the transfer of a U.S. government contract through the required novation process. In two recent decisions, the Government Accountability Office considered the impact of such transactions and the novation process on the pursuit of new task orders from the U.S. government, with disappointing results for…

Inside Government Contracts

4 Considerations For Gov’t Contractor Carveout Deals

By Scott A. Freling & Alexander Hastings

May 22, 2018

[This article was originally published in Law360.] A steady flow of M&A activity in the government contracts industry continues. Indeed, last year we saw over 100 publicly reported deals involving government contractors, and this pace has continued into 2018. This M&A activity has taken a variety of forms, including a number of “carveout” transactions, where a government-focused business is separated from its existing corporate structure. For instance, earlier this month L3 announced an agreement…

Inside Government Contracts

Fraudulent SAM Accounts Lead to More Complicated SAM Registration Requirements

By Scott A. Freling & Alexander Hastings

April 3, 2018

GSA recently announced it is supporting an Inspector General investigation into alleged, third-party fraudulent activity in the System for Award Management (“SAM”). The GSA announcement suggests that fraudulent SAM accounts may have been used to divert certain federal payments to unauthorized bank accounts. The announcement does not elaborate on the scope of potentially impacted entities or the amount of misdirected payments at issue. GSA has advised impacted entities to validate their SAM registration and confirm…

Alexander Hastings

Trump Administration Renews Focus on Anti-Human Trafficking Efforts

Trump Administration Renews Focus on Anti-Human Trafficking Efforts

Momentum In Drug Pricing Reform: House Passes New Legislation on the Heels of Presidential Candidates’ Drug Pricing Proposals

Momentum In Drug Pricing Reform: House Passes New Legislation on the Heels of Presidential Candidates’ Drug Pricing Proposals

How Much Is Enough? Federal Circuit Appeal May Decide Level of U.S. Manufacturing Required Under the TAA

How Much Is Enough? Federal Circuit Appeal May Decide Level of U.S. Manufacturing Required Under the TAA

Rights in Government-Funded IP: Changes May be on the Horizon

More Novation Complexity In Gov’t Contracts M&A?

4 Considerations For Gov’t Contractor Carveout Deals

Fraudulent SAM Accounts Lead to More Complicated SAM Registration Requirements

Stay Connected

Company

Support

New to the Network